executive vice president and chief financial officer and Andrew Finkle executive vice president, general counsel and secretary...Vidamed Inc., of Fremont, Calif., appointed Diane M. Anderson vice president of sales and marketing

Celera Genomics, of Rockville, Md., named Jason Molle senior vice president of sales and marketing, and Peter Chambre chief operating officer

Matrix Pharmaceutical Inc., of Fremont, Calif., named Jeanette Fritzky vice president of sales and marketing...Russell Granzow vice president, marketing, sales and business development...and Scott Rakestraw executive director of therapeutics business development

Enmed Inc., of Burlington, Mass., appointed Randolph Hubbell vice president of sales and Patricia O'Brien vice president of quality and regulatory affairs...It also named Robert Touslee vice president and chief intellectual property officer

InterMune Pharmaceuticals Inc., of Burlingame, Calif., named Stephen Rosenfield senior vice president of legal affairs and general counsel, and David Cory vice president of sales and marketing

PathoGenesis Corp., of Seattle, named Dinu Sen senior vice president of sales and marketing

and John Penn, vice chairman and CEO of Satellite Industries...Atrix Laboratories Inc., of Fort Collins, Colo., named Magnus Pelles vice president of sales and marketing for its European operations...and Bruce Chabner, director of the Clinical Cancer Center and chief of the division of hematology/oncology at Massachusetts General Hospital

Cephalon Inc., of West Chester, Pa., promoted Carl Savini to senior vice president, and named Roy Craig vice president of sales and Reinhard Koenig vice president, medical affairs

and Michael Wokasch, corporate senior vice president, strategic operations...Entelos Inc., of Menlo Park, Calif., appointed John Andrews executive vice president of sales and marketing...GeneLink Inc., of Margate, N.J., named Joseph Franckewitz vice president of sales and marketing

Matritech Inc., of Newton, Mass., appointed Robert Morgan chief financial officer and Patrick Maley vice president for sales and marketing. • Pharmacopoeia Inc., of Princeton, N.J., named John Babiak vice president of technology. • RiboGene Inc., of Hayward, Calif., named Anastassios Retzios director of clinical operations. • Sanguinex Inc., of Raleigh, N.C., appointed Robert Timmins, former CEO of Organon Teknika, to its board of directors. • Small Molecule Therapeutics Inc., of Monmouth

and Kurt Gustafson to treasurer. • AtheroGenics Inc., of Norcross, Ga., appointed Don Kirksey to vice president of business and corporate development. • BioMira Inc., of Edmonton, Alberta, appointed Mark Young chief operating officer. • CarboMed Inc., of Brentwood, Tenn., named John Watson president and CEO. • Cellomics Inc., of Pittsburgh, named Alan Seadler vice president of operations, and Michael Nemzek senior vice president of sales and marketing. • ChiRex Inc., of Stamford, Conn

o Quidel Corp., of San Diego, named Robert Buchs vice president of sales and distribution management

and chief financial officer of SmithKline Beecham plc, of London. * Clinical reSearchNet Inc., of Kirkland, Wash., named Michael Woods director of business development and Frazier Miller manager of marketing development. * Cognetix Inc., of Salt Lake City, appointed Brian Anderson executive vice president of corporate development. * Collateral Therapeutics Inc., of San Diego, named to its scientific advisory board John Ross, professor of medicine at the University of California, San Diego

Connetics Corp., of Palo Alto, Calif., appointed Robert Lederer senior vice president of sales and marketing and Katrina Church vice president of legal affairs and corporate counsel. * Copernicus Gene Systems Inc., of Beachwood, Ohio, named Thomas Barnish vice president of finance and chief operating officer. * Cortech Inc., of Denver, appointed the following to its board of directors: Joachim von Roy, founder of RvR Associates

and Richard Lerner, president of The Scripps Research Institute. * CytRx Corp., of Atlanta, named as chairman Max Link, former chairman of Sandoz Ltd. * DiagnoCure Inc., of Quebec City, Quebec, appointed to its scientific advisory committee Tak Wah Mak, of the University of Toronto, and Richard Boucher, of the University of North Carolina. * Ekos Corp., of Bothell, Wash., appointed Mark Low vice president of sales and marketing. * Endorex Corp., of Chicago, appointed as scientific

AltaRex Corp., of Edmonton, Alberta, named Richard Bagley president and CEO. * Alza Corp., of Palo Alto, Calif., appointed Jay Shepard vice president of sales. * Amrad Corp., of Victoria, Australia, named as a director Adrienne Clarke, lieutenant governor of Victoria and director of the plant cell biology research center at the University of Melbourne. * Aurora Biosciences Corp., of San Diego, appointed Tad Hurst vice president of pharmaco-informatics. * BioChem Pharma Inc., of Laval

Roche Global Development is part of Roche Holding Ltd., of Basel, Switzerland. * Scotia Pharmaceuticals Ltd., of Stirling, Scotland, appointed Christopher Blackwell development director and Margaret Thomson head of clinical operations. * Sensus Corp., of Austin, Texas, appointed Magnus Precht senior vice president for sales and marketing. * Targeted Genetics Corp., of Seattle, appointed David Schubert director of communications and strategic relations. * TheraTech Inc., of Salt Lake City

and Angela Hartley, corporate communications and investor relations. * La Jolla Pharmaceutical Co., of San Diego, named Peter Ulrich executive vice president. * MGI PHARMA Inc., of Minneapolis, made the following appointments: James Adam, chief operating officer...and John MacDonald, vice president of research and development. * Neurogen Corp., of Branford, Conn., named James Krause vice president for biochemistry. * Nextran Inc., of Princeton, N.J., named Donald Charlton director of

It also named as chairman Joseph Ashley, chairman of ProCyte Corp., and as directors Allen Ford, consultant to the TransAction Group, and Glenn Corlett, dean of the school of business at Ohio University. * Diversa Corp., of San Diego, appointed William Baum vice president of sales and marketing. * EnzyMed Inc., of Iowa City, Iowa, appointed to its scientific advisory board Kent Kirk, professor of bacteriology at University of Wisconsin, Madison. * Gene Logic Inc., of Columbia, Md., named